“The opportunity of applying systematic examination for genetic variants in a range of pathogens will have major benefits for global public health. This program, with Oracle as a partner, takes us a step closer to this goal.”
The emergence of more infectious variants of the COVID-19 virus is threatening to slow the global pandemic recovery and thwart current vaccine immunity. To speed identification of these variants, Oxford University and Oracle have created a Global Pathogen Analysis System, which uses a global common standard for analyzing the virus and enhances the ability to process pathogen data in just minutes. The platform is free for researchers and non-profits to use worldwide and is currently being used by institutions on nearly every continent.
Combining Oxford’s Scalable Pathogen Platform (SP³) with the services and power of Oracle Cloud, the offering securely unifies and analyzes data from around the globe to provide better intelligence on variants and their potential to spread. SP³’s processing capability has been enhanced with extensive new development work from Oracle enabling high-performance and security plus 7 by 24 worldwide availability of the SP³ system in the Oracle Cloud.
Oracle works with the public sector, NGOs, and private industry to deliver results for sick and vulnerable people around the world.
None of us is untouched by COVID-19, so given the chance to do something to combat the disease, Oracle teammates have jumped into action. From writing code to putting free cloud resources into researchers’ hands, Oracle employees have rallied around a shared sense of purpose to commit their time, talent, and passion to the fight. “Being part of the solution is exactly what I wanted to be doing,” says Sharon Kennedy, a member of the Oracle APEX technical staff.
Because of the accelerated timelines, the original clinical trials for COVID-19 specifically excluded certain groups, such as people who knew they were pregnant. But with the CDC’s v-safe system, developed by Oracle, people who didn’t know and/or those who did know they were pregnant at the time they received a COVID-19 vaccine were able to opt in, share health updates, and track any reactions to the vaccine. Thanks to millions of records in the system, researchers were able to conclude that there were no adverse effects from the vaccine on pregnant people.
Every day, public health policymakers study graphs and visualizations to understand the state of the global pandemic. They need a reliable central data source. The Centers for Disease Control uses Oracle National EHR Cloud as a central data repository for US vaccination data. Anonymized data—where all patient names and identifiers have been removed to protect patient privacy—is used for analysis and reporting by authorized agencies and organizations.
The Tony Blair Institute and Oracle have partnered to use the Oracle National EHR Cloud System to manage the distribution of yellow fever vaccine in Africa. More than 70,000 people in Ghana were vaccinated during the first week of the program. We’re talking with dozens of countries about how to modernize their national public health infrastructure and enable efficient vaccine distribution, therapeutic monitoring, and diagnostic testing using Oracle Cloud and Public Health Applications.
Oracle Cloud Infrastructure (OCI) delivers high performance computing power to securely run the most critical workloads.
Oracle Application Express (APEX) is a low code development platform that enables people to build scalable, secure applications.
Oracle Exadata Cloud Service runs Oracle Database workloads in the cloud, improving security, performance, and uptime.
Oracle Analytics Cloud with Oracle R is embedded with machine learning to help organizations discover unique insights faster with automation and intelligence.